CCR7 and COVID-19: We provide a comprehensive immunological map of PBMCs in patients with moderately severe CAP at single-cell protein level, revealing monocyte MCs with immunosuppressive features and enhanced chemokine receptor expression, and disclosing increased classical monocyte CCR7 expression as a feature unique to CAP when compared with COVID-19.